Goff Brian
Chief Executive Officer at AGIO; EVP & Chief Commercial Officer at ALEXION PHARMACEUTICALS INC
- Sold, on record
- $5.8M
- Dollars the filings state
- Form 4 sales
- 15
- Latest Apr 2, 2026
- Form 144 notices
- 9
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- AGIOAGIOS PHARMACEUTICALS, INC.Chief Executive Officer
- ALEXION PHARMACEUTICALS INCEVP & Chief Commercial Officer
Sales by reason
13
Routine
2
Plan not stated
0
No plan
0
Unusual
Form 4 sales per year, every sale on record.
Sales by company
- AGIO167,248 shares
- ALEXION PHARMACEUTICALS INC3,296 shares
Shares sold, every Form 4 sale on record.
Timeline
- Apr 2, 2026Routine
Sold 9.4% of their holdings
$662k19,068 shares at $34.71
- Apr 2, 2026Notice
Filed a notice to sell 19,068 shares
$652k19,068 shares
- Mar 2, 2026Routine
Sold 9.9% of their holdings
$523k18,055 shares at $28.96
- Mar 2, 2026Notice
Filed a notice to sell 18,055 shares
$546k18,055 shares
- Dec 30, 2025Routine
Sold 11.6% of their holdings
$507k18,703 shares at $27.09
- Dec 30, 2025Notice
Filed a notice to sell 18,703 shares
$508k18,703 shares
- Aug 8, 2025Routine
Sold 8.2% of their holdings
$406k11,085 shares at $36.67
- Aug 8, 2025Notice
Filed a notice to sell 11,085 shares
$411k11,085 shares
- Jun 24, 2025Routine
Sold 14.3% of their holdings
$627k18,700 shares at $33.54
- Jun 24, 2025Notice
Filed a notice to sell 18,507 shares
$637k18,507 shares
10 of 24
Every transaction
| Traded | Filed | Stock | Role | What | Amount | Price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|---|---|
| Jun 18, 2026 | Jun 23, 2026 | AGIO | Chief Executive Officer | Exercised or settledPerformance share units | 39,000 | 39,000 | SEC | ||
| Jun 18, 2026 | Jun 23, 2026 | AGIO | Chief Executive Officer | AwardedRestricted stock units | 39,000 | 39,000 | SEC | ||
| Jun 9, 2026 | Jun 10, 2026 | NTLA | Director | AwardedStock Option (right to buy) | 13,300 | 13,300 | SEC | ||
| Jun 9, 2026 | Jun 10, 2026 | NTLA | Director | Awarded | 9,200 | 32,609 | SEC | ||
| Apr 2, 2026 | Apr 6, 2026 | AGIO | Chief Executive Officer | Sold | 19,068 | $34.71 | $662k | 184,508 | SEC |
| Apr 2, 2026 | Apr 6, 2026 | AGIO | Chief Executive Officer | Exercised or settledPerformance share units | 39,028 | 40,500 | SEC | ||
| Apr 2, 2026 | Apr 6, 2026 | AGIO | Chief Executive Officer | Exercised options | 39,028 | 191,104 | SEC | ||
| Mar 2, 2026 | Mar 3, 2026 | AGIO | Chief Executive Officer | Sold | 18,055 | $28.96 | $523k | 164,548 | SEC |
| Mar 2, 2026 | Mar 3, 2026 | AGIO | Chief Executive Officer | Exercised or settledRestricted stock units | 39,500 | 26,000 | SEC | ||
| Mar 2, 2026 | Mar 3, 2026 | AGIO | Chief Executive Officer | Exercised options | 39,500 | 170,466 | SEC | ||
| Mar 1, 2026 | Mar 3, 2026 | AGIO | Chief Executive Officer | AwardedRestricted stock units | 222,000 | 174,000 | SEC | ||
| Dec 30, 2025 | Jan 2, 2026 | AGIO | Chief Executive Officer | Sold | 18,703 | $27.09 | $507k | 143,103 | SEC |
| Dec 30, 2025 | Jan 2, 2026 | AGIO | Chief Executive Officer | Exercised or settledPerformance share units | 38,278 | 0 | SEC | ||
| Dec 30, 2025 | Jan 2, 2026 | AGIO | Chief Executive Officer | Exercised options | 38,278 | 149,333 | SEC | ||
| Aug 8, 2025 | Aug 12, 2025 | AGIO | Chief Executive Officer | Sold | 11,085 | $36.67 | $406k | 123,528 | SEC |
| Aug 8, 2025 | Aug 12, 2025 | AGIO | Chief Executive Officer | Exercised or settledRestricted stock units | 22,691 | 0 | SEC | ||
| Aug 8, 2025 | Aug 12, 2025 | AGIO | Chief Executive Officer | Exercised options | 22,691 | 134,613 | SEC | ||
| Jun 24, 2025 | Jun 26, 2025 | AGIO | Chief Executive Officer | Sold | 18,700 | $33.54 | $627k | 111,922 | SEC |
| Jun 24, 2025 | Jun 26, 2025 | AGIO | Chief Executive Officer | Exercised or settledPerformance share units | 38,277 | 12,750 | SEC | ||
| Jun 24, 2025 | Jun 26, 2025 | AGIO | Chief Executive Officer | Exercised options | 38,277 | 118,151 | SEC | ||
| Jun 11, 2025 | Jun 13, 2025 | NTLA | Director | AwardedStock Option (right to buy) | 11,450 | 11,450 | SEC | ||
| Jun 11, 2025 | Jun 13, 2025 | NTLA | Director | Awarded | 8,000 | 23,409 | SEC | ||
| Mar 3, 2025 | Mar 4, 2025 | AGIO | Chief Executive Officer | Sold | 12,947 | $35.54 | $460k | 92,345 | SEC |
| Mar 1, 2025 | Mar 4, 2025 | AGIO | Chief Executive Officer | Exercised or settledRestricted stock units | 26,500 | 36,000 | SEC | ||
| Mar 1, 2025 | Mar 4, 2025 | AGIO | Chief Executive Officer | Exercised options | 26,500 | 101,139 | SEC | ||
| Mar 1, 2025 | Mar 4, 2025 | AGIO | Chief Executive Officer | AwardedRestricted stock units | 181,500 | 142,500 | SEC | ||
| Aug 8, 2024 | Aug 12, 2024 | AGIO | Chief Executive Officer | Sold | 11,091 | $42.75 | $474k | 78,792 | SEC |
| Aug 8, 2024 | Aug 12, 2024 | AGIO | Chief Executive Officer | Exercised or settledRestricted stock units | 22,691 | 22,691 | SEC | ||
| Aug 8, 2024 | Aug 12, 2024 | AGIO | Chief Executive Officer | Exercised options | 22,691 | 89,883 | SEC | ||
| Jun 13, 2024 | Jun 17, 2024 | NTLA | Director | AwardedStock Option (right to buy) | 22,297 | 22,297 | SEC | ||
| Jun 13, 2024 | Jun 17, 2024 | NTLA | Director | Awarded | 15,409 | 15,409 | SEC | ||
| Jun 5, 2024 | Jun 7, 2024 | AGIO | Chief Executive Officer | Sold | 12,115 | $48.84 | $592k | 67,192 | SEC |
| Jun 5, 2024 | Jun 7, 2024 | AGIO | Chief Executive Officer | Exercised or settledPerformance share units | 25,527 | 76,583 | SEC | ||
| Jun 5, 2024 | Jun 7, 2024 | AGIO | Chief Executive Officer | Exercised options | 25,527 | 79,307 | SEC | ||
| Mar 5, 2024 | Mar 5, 2024 | AGIO | Chief Executive Officer | Sold | 4,156 | $32.57 | $135k | 53,780 | SEC |
| Mar 1, 2024 | Mar 5, 2024 | AGIO | Chief Executive Officer | Exercised or settledRestricted stock units | 8,500 | 17,000 | SEC | ||
| Mar 1, 2024 | Mar 5, 2024 | AGIO | Chief Executive Officer | Exercised options | 8,500 | 57,936 | SEC | ||
| Mar 1, 2024 | Mar 5, 2024 | AGIO | Chief Executive Officer | AwardedRestricted stock units | 249,500 | 195,500 | SEC | ||
| Jan 24, 2024 | Jan 24, 2024 | AGIO | Chief Executive Officer | Sold | 7,635 | $21.64 | $165k | 49,436 | SEC |
| Jan 20, 2024 | Jan 24, 2024 | AGIO | Chief Executive Officer | Exercised or settledPerformance share units | 17,018 | 102,110 | SEC | ||
| Jan 20, 2024 | Jan 24, 2024 | AGIO | Chief Executive Officer | Exercised options | 17,018 | 57,071 | SEC | ||
| Jan 9, 2024 | Jan 9, 2024 | AGIO | Chief Executive Officer | Sold | 12,066 | $22.99 | $277k | 40,053 | SEC |
| Jan 5, 2024 | Jan 9, 2024 | AGIO | Chief Executive Officer | Exercised or settledPerformance share units | 25,527 | 119,128 | SEC | ||
| Jan 5, 2024 | Jan 9, 2024 | AGIO | Chief Executive Officer | Exercised options | 25,527 | 52,119 | SEC | ||
| Aug 8, 2023 | Aug 10, 2023 | AGIO | Chief Executive Officer | Sold | 10,178 | $25.48 | $259k | 26,592 | SEC |
| Aug 8, 2023 | Aug 10, 2023 | AGIO | Chief Executive Officer | Exercised or settledRestricted stock units | 22,691 | 45,382 | SEC | ||
| Aug 8, 2023 | Aug 10, 2023 | AGIO | Chief Executive Officer | Exercised options | 22,691 | 36,770 | SEC | ||
| Jun 30, 2023 | Jun 30, 2023 | AGIO | Chief Executive Officer | Sold | 11,449 | $28.36 | $325k | 14,079 | SEC |
| Jun 28, 2023 | Jun 30, 2023 | AGIO | Chief Executive Officer | Exercised or settledPerformance share units | 25,528 | 144,655 | SEC | ||
| Jun 28, 2023 | Jun 30, 2023 | AGIO | Chief Executive Officer | Exercised options | 25,528 | 25,528 | SEC |
Page 1
Sales and notices (24)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Apr 2, 2026 | Apr 6, 2026 | AGIO | Chief Executive Officer | Form 4 sale | 19,068 | $662k | 9.4% | Routine | SEC |
| Apr 2, 2026 | Apr 2, 2026 | AGIO | Chief Executive Officer | Form 144 notice | 19,068 | $652k | Notice | SEC | |
| Mar 2, 2026 | Mar 3, 2026 | AGIO | Chief Executive Officer | Form 4 sale | 18,055 | $523k | 9.9% | Routine | SEC |
| Mar 2, 2026 | Mar 2, 2026 | AGIO | Chief Executive Officer | Form 144 notice | 18,055 | $546k | Notice | SEC | |
| Dec 30, 2025 | Jan 2, 2026 | AGIO | Chief Executive Officer | Form 4 sale | 18,703 | $507k | 11.6% | Routine | SEC |
| Dec 30, 2025 | Dec 30, 2025 | AGIO | Chief Executive Officer | Form 144 notice | 18,703 | $508k | Notice | SEC | |
| Aug 8, 2025 | Aug 12, 2025 | AGIO | Chief Executive Officer | Form 4 sale | 11,085 | $406k | 8.2% | Routine | SEC |
| Aug 8, 2025 | Aug 8, 2025 | AGIO | Chief Executive Officer | Form 144 notice | 11,085 | $411k | Notice | SEC | |
| Jun 24, 2025 | Jun 26, 2025 | AGIO | Chief Executive Officer | Form 4 sale | 18,700 | $627k | 14.3% | Routine | SEC |
| Jun 24, 2025 | Jun 24, 2025 | AGIO | Chief Executive Officer | Form 144 notice | 18,507 | $637k | Notice | SEC | |
| Mar 3, 2025 | Mar 4, 2025 | AGIO | Chief Executive Officer | Form 4 sale | 12,947 | $460k | 12.3% | Routine | SEC |
| Mar 3, 2025 | Mar 3, 2025 | AGIO | Chief Executive Officer | Form 144 notice | 12,947 | $460k | Notice | SEC | |
| Aug 8, 2024 | Aug 12, 2024 | AGIO | Chief Executive Officer | Form 4 sale | 11,091 | $474k | 12.3% | Routine | SEC |
| Aug 8, 2024 | Aug 8, 2024 | AGIO | Chief Executive Officer | Form 144 notice | 11,091 | $474k | Notice | SEC | |
| Jun 6, 2024 | Jun 5, 2024 | AGIO | Chief Executive Officer | Form 144 notice | 12,115 | $592k | Notice | SEC | |
| Jun 5, 2024 | Jun 7, 2024 | AGIO | Chief Executive Officer | Form 4 sale | 12,115 | $592k | 15.3% | Routine | SEC |
| Mar 5, 2024 | Mar 5, 2024 | AGIO | Chief Executive Officer | Form 4 sale | 4,156 | $135k | 7.2% | Routine | SEC |
| Mar 1, 2024 | Mar 1, 2024 | AGIO | Chief Executive Officer | Form 144 notice | 4,156 | $134k | Notice | SEC | |
| Jan 24, 2024 | Jan 24, 2024 | AGIO | Chief Executive Officer | Form 4 sale | 7,635 | $165k | 13.4% | Routine | SEC |
| Jan 9, 2024 | Jan 9, 2024 | AGIO | Chief Executive Officer | Form 4 sale | 12,066 | $277k | 23.2% | Routine | SEC |
| Aug 8, 2023 | Aug 10, 2023 | AGIO | Chief Executive Officer | Form 4 sale | 10,178 | $259k | 27.7% | Routine | SEC |
| Jun 30, 2023 | Jun 30, 2023 | AGIO | Chief Executive Officer | Form 4 sale | 11,449 | $325k | 44.8% | Routine | SEC |
| Jun 8, 2018 | Jun 12, 2018 | ALEXION PHARMACEUTICALS INC | EVP & Chief Commercial Officer | Form 4 sale | 1,645 | $195k | 4.3% | Plan not stated | SEC |
| Feb 8, 2018 | Feb 8, 2018 | ALEXION PHARMACEUTICALS INC | EVP & Chief Commercial Officer | Form 4 sale | 1,651 | $192k | 5.4% | Plan not stated | SEC |